Shares of Senseonics Holdings, a medical technology company focused on the development and manufacturing of continuous glucose monitoring systems, surged 5.78% in pre-market trading on Friday.
HC Wainwright & Co. maintained its "Buy" rating and a $2.00 price target on Senseonics, indicating potential upside for the stock. The analyst action appears to be driving the pre-market rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments